本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

190.88
-3.0725-1.58%
成交量:82.11万
成交额:1.57亿
市值:409.12亿
市盈率:-21.40
高:193.61
开:191.57
低:190.12
收:193.95
52周最高:224.31
52周最低:47.45
股本:2.14亿
流通股本:1.85亿
量比:0.72
换手率:0.44%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
净资产收益率:-79.09%
总资产收益率:-30.12%
市净率:15.70
市盈率(LYR):-32.08

数据加载中...

2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/05

重要事件披露

Form 8-K - Current report
2024/12/04

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/25

重要事件披露

Form 8-K - Current report
2024/10/23

重要事件披露

Form 8-K - Current report